EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment

Anu Sharma iD, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, Andrea Ortiz Rocha, Nathaly Cuervo-Pardo, Jens Rosenberg, Pierre Bedossa, Romina Lomonaco, Fernando Bril, Diana Barb, Kenneth Cusi iD

Journal of the Endocrine Society · 05.12.2025 · 10 (1)

DOI: 10.1210/jendso/bvaf209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 16.12.2025. Verfasst von Anu Sharma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, FL 32610, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Echosens.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The fibrosis-4 index (FIB-4) index is recommended to identify adults with metabolic dysfunction-associated steatotic liver disease (MASLD) and clinically significant fibrosis (moderate to advanced fibrosis or ≥F2). However, it is less reliable in young adults (age <45 years).

Objective

The aim was to assess whether cardiometabolic risk factors [CMRFs: type 2 diabetes (T2D), hypertension, obesity] or insulin resistance (IR) improved MASLD fibrosis risk stratification in young adults.

Methods

Adults with/without T2D and no history of MASLD attending outpatient clinics underwent screening with vibration-controlled transient elastography for ≥F2 (liver stiffness measurement ≥ 8.0 kPa). Magnetic resonance elastography and/or liver biopsy were performed if indicated for diagnosis confirmation.

Results

Of the 964 adults, 25% were young adults and 75% were 45 to 64 years, with the prevalence of ≥F2: 7% vs 9% (P = .29), respectively. In young adults, clinically significant fibrosis was unlikely in those without homeostatic model assessment of insulin resistance (HOMA-IR) or CMRFs [negative predictive value (NPV) 97-100; 95% confidence interval 94-100]. Performance of FIB-4 ≥ 1.3 had low sensitivity (15%) and positive predictive value (25%) but good specificity (97%) and NPV (95%), whereas having 3 CMRFs alone performed better (sensitivity 75%, specificity 71%). Adding FIB-4 ≥ 1.3 to CMRFs worsened sensitivity (8%) while improving specificity (100%). Adding the HOMA-IR to CMRFs improved the sensitivity (75% to 78%) and specificity (75% to 81%) of CMRFs alone. Adding 2 CMRFs to the FIB-4 in the older age group improved both sensitivity and specificity of the FIB-4.

Conclusion

In young adults, the absence of CMRFs or IR makes clinically significant fibrosis unlikely. Measuring IR improved risk stratification in young adults with CMRFs. Using CMRFs with IR may improve the detection of clinically significant fibrosis in young adults.

Schlagwörter

Stichwörter der Autor:innen

MASLD/NAFLDcardiometabolic risk factorsdiabetes mellitus type 2obesityyoung adults

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, FL 32610, USA.
  • Advanced Magnetic Resonance Imaging and Spectroscopy Facility, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.
  • Department of Pathology, Hôspital Beaujon, AP-HP Nord, Clichy 92110, France.
  • Division of Endocrinology, Diabetes and Metabolism, University of Alabama, Birmingham, AL 35294, USA.

ORCID-Profile: Anu Sharma, Kenneth Cusi

Förderung

  • National Institutes of Health
  • Echosens

Zitieren

APA

Sharma, A., Godinez Leiva, E., Kalavalapalli, S., Ortiz Rocha, A., Cuervo-Pardo, N., Rosenberg, J., Bedossa, P., Lomonaco, R., Bril, F., Barb, D., & Cusi, K. (2025). Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment. Journal of the Endocrine Society, 10(1). https://doi.org/10.1210/jendso/bvaf209

Vancouver

Sharma A, Godinez Leiva E, Kalavalapalli S, Ortiz Rocha A, Cuervo-Pardo N, Rosenberg J, et al. Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment. Journal of the Endocrine Society. 2025;10(1). doi:10.1210/jendso/bvaf209

BibTeX
@article{Sharma2025,
  author = {Sharma, Anu and Godinez Leiva, Eddison and Kalavalapalli, Srilaxmi and Ortiz Rocha, Andrea and Cuervo-Pardo, Nathaly and Rosenberg, Jens and Bedossa, Pierre and Lomonaco, Romina and Bril, Fernando and Barb, Diana and Cusi, Kenneth},
  title = {Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment},
  journal = {Journal of the Endocrine Society},
  year = {2025},
  volume = {10},
  number = {1},
  doi = {10.1210/jendso/bvaf209}
}
Kostenlos starten →